ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
2023 EHA® Insights: "Results From the Ph3 PhALLCON of Ponatinib vs. Imatinib in Combination With Reduced-Intensity Chemotherapy in Newly Diagnosed Ph+ ALL"
By
ecancer
FEATURING
Elias Jabbour
By
ecancer
FEATURING
Elias Jabbour
Login to view comments.
Click here to Login
